[molongui_author_posts count=100 list_divider=”yes” show_date=”yes”]
“Acid Revival” portrays a resurrected scientific field, notably more conservative than its historic predecessor
Through candid interviews with modern psychedelic researchers, Danielle Giffort’s "Acid Revival" presents a profession obsessed with how it is perceived by mainstream audiences and desperate not to repeat the “mistakes” of the 1960s.
COMPASS Pathways Is Trying to Patent Psilocybin for More Mental Health Conditions Than You Can Name
News that COMPASS Pathways is attempting to patent psychedelic therapy room specifications and therapist behaviors started an online firestorm about the company’s “monopolistic and shady behaviors,” but so far the debates have missed the biggest threats lurking in COMPASS’s international patent applications.
MAPS Canada’s “Clarifying Misinformation” Letter by Mark Haden is Full of Misinformation
In response to Psymposia's reporting on outgoing MAPS Canada Executive Director Mark Haden's resignation following a year full of controversies, Haden published a statement entitled “Clarifying Misinformation” that was full of misinformation and factual inaccuracies. In the following article, we set the record straight.
The Third Wave’s Paul Austin Has Been Accused of Stealing Information For His Psychedelic Provider Directory
The Third Wave copied information from Psychedelic.Support and MAPS Integration List without permission to use for its own directory.
COMPASS Pathways’ Psilocybin Patent Questioned By UK Patent Examiner
While COMPASS has issued a response defending the validity of its patents, one of the co-inventors says the patent examiner’s opinion is probably “a valid one.”
Hamilton Morris Hired by Psilocybin Startup COMPASS Pathways, Ends “Hamilton’s Pharmacopeia” On Vice
Hamilton Morris, the creator of Vice’s “Hamilton’s Pharmacopeia,” will cease working with Vice on the show following the third season. He has joined psychedelic pharmaceutical corporation COMPASS Pathways as a chemistry consultant.
DoubleBlind Claims Its Ad Was the ‘First-Ever’ U.S. Psychedelic Destigmatization Campaign — It Wasn’t
DoubleBlind claims its recently-unveiled New York City billboard is a lot of things, except what it actually is: a giant advertisement.
MAPS Canada’s Data Breach Foreshadows Corporadelic Future
As the psychedelic pharmaceutical industry increasingly prioritizes personal data extraction through mobile apps, wearables, and so-called “targeted” medicine, a recent data breach by former MAPS Canada Executive Director Mark Haden provides a warning about some of the possible consequences to the financial incentives of datafication.
New Website Details Abuse Allegations Against German Psychedelic Practitioners
A new website — whoisjoeschraube.com — alleges that Joe Schraube and Miguel Delgado have taken advantage of positions of power and abused people under the influence of psychedelics.
The Masters of Bad Trips
As proponents of psychedelics begin to grapple with legacies of abuse, it’s time to learn from victims themselves. Psymposia is co-producing an investigative podcast series, Power Trip, with New York Magazine.